Earnings estimate | Current qtr. (Jun 2022) | Next qtr. (Sep 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
No. of analysts | 1 | 1 | 3 | 3 |
Avg. Estimate | 0.89 | 1.04 | 4.03 | 4.35 |
Low estimate | 0.89 | 1.04 | 3.81 | 4.15 |
High estimate | 0.89 | 1.04 | 4.15 | 4.47 |
Year ago EPS | 0.98 | 1.26 | 3.89 | 4.03 |
Revenue estimate | Current qtr. (Jun 2022) | Next qtr. (Sep 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
No. of analysts | 2 | 2 | 3 | 3 |
Avg. Estimate | 9.17B | 10.06B | 38.72B | 37.22B |
Low estimate | 7.34B | 8.28B | 32.04B | 31.47B |
High estimate | 11.01B | 11.83B | 45.6B | 46.77B |
Year ago sales | 11.31B | N/A | 46.91B | 38.72B |
Sales growth (year/est) | -18.90% | N/A | -17.50% | -3.90% |
Earnings history | 29/06/2021 | 29/09/2021 | 30/12/2021 | 30/03/2022 |
---|---|---|---|---|
Est. EPS | 0.64 | 1.01 | 0.81 | 0.92 |
Actual EPS | 0.98 | 1.26 | 0.86 | 1.09 |
Difference | 0.34 | 0.25 | 0.05 | 0.17 |
Surprise % | 53.10% | 24.80% | 6.20% | 18.50% |
EPS trend | Current qtr. (Jun 2022) | Next qtr. (Sep 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
Current estimate | 0.89 | 1.04 | 4.03 | 4.35 |
7 days ago | 0.71 | 0.83 | 3.22 | 3.48 |
30 days ago | 0.71 | 0.83 | 3.24 | 3.5 |
60 days ago | 0.71 | 0.83 | 3.32 | 3.55 |
90 days ago | 0.73 | 0.86 | 3.28 | 3.52 |
EPS revisions | Current qtr. (Jun 2022) | Next qtr. (Sep 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | GSK | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | -9.20% | N/A | N/A | N/A |
Next qtr. | -17.50% | N/A | N/A | N/A |
Current year | 3.60% | N/A | N/A | N/A |
Next year | 7.90% | N/A | N/A | N/A |
Next 5 years (per annum) | 8.20% | N/A | N/A | N/A |
Past 5 years (per annum) | 4.75% | N/A | N/A | N/A |